Morphine tolerance does not develop in mice treated with endothelin-A receptor antagonists

Brain Research

Volumn 1064, Issue 1-2, 2005, Pages 126-135

  Bhalla, Shaifali ^a,b   Matwyshyn, George ^a   Gulati, Anil ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

BMS182874 (5 (dimethylamino) N (3,4 dimethyl 5 isoxazolyd) 1 naphthalenesulfonamide); BQ123 Cyclo( D Trp D Asp Pro D Val Leu) ; Central nervous system; Endothelin; Morphine; Tolerance

Indexed keywords

5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG POTENTIATION; MALE; MOLECULAR INTERACTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SINGLE DRUG DOSE; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; DANSYL COMPOUNDS; DRUG INTERACTIONS; DRUG TOLERANCE; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MORPHINE; NALOXONE; PAIN THRESHOLD; PEPTIDES, CYCLIC; RECEPTOR, ENDOTHELIN A; RECEPTORS, OPIOID;

ANIMALIA;

EID: 28844452447     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.09.054     Document Type: Article

References (64)

1. R.M. Allen, and L.A. Dykstra Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-d-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude J. Pharmacol. Exp. Ther. 295 2000 1012 1021
2. R.M. Allen, and L.A. Dykstra Role of morphine maintenance dose in the development of tolerance and its attenuation by an NMDA receptor antagonist Psychopharmacology (Berlin) 148 2000 59 65
3. S. Bhalla, G. Matwyshyn, and A. Gulati Potentiation of morphine analgesia by BQ123, an endothelin antagonist Peptides 23 2002 1837 1845
4. S. Bhalla, G. Matwyshyn, and A. Gulati Endothelin receptor antagonists restore morphine analgesia in morphine tolerant rats Peptides 24 2003 553 561
5. A.D. Blake, G. Bot, J.C. Freeman, and T. Reisine Differential opioid agonist regulation of the mouse mu opioid receptor J. Biol. Chem. 272 1997 782 790
6. L.M. Bohn, R.J. Lefkowitz, R.R. Gainetdinov, K. Peppel, M.G. Caron, and F.T. Lin Enhanced morphine analgesia in mice lacking beta-arrestin 2 Science 286 1999 2495 2498
7. L.M. Bohn, R.R. Gainetdinov, F.T. Lin, R.J. Lefkowitz, and M.G. Caron Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence Nature 408 2000 720 723
8. S. Chakrabarti, M. Oppermann, and A.R. Gintzler Chronic morphine induces the concomitant phosphorylation and altered association of multiple signaling proteins: a novel mechanism for modulating cell signaling Proc. Natl. Acad. Sci. U. S. A. 98 2001 4209 4214
9. F.E. D'Amour, and D.L. Smith A method for determining loss of pain sensation J. Pharmacol. Exp. Ther. 71 1941 74 79
10. A.K. Finn, and J.L. Whistler Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal Neuron 32 2001 829 839
11. M.E. Fundytus, J. Ritchie, and T.J. Coderre Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists Br. J. Pharmacol. 120 1997 1015 1020
12. K.R. Gogas, R.W. Presley, J.D. Levine, and A.I. Basbaum The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression Neuroscience 42 1991 617 628
13. C.S. Goodchild, R. Nadeson, and E. Cohen Supraspinal and spinal cord opioid receptors are responsible for antinociception following intrathecal morphine injections Eur. J. Anaesthesiol. 21 2004 179 185
14. A. Gulati, and R.C. Srimal Endothelin mechanisms in the central nervous system: a target for drug development Drug Dev. Res. 26 1992 361 387
15. A. Gulati, S. Rebello, S. Roy, and P.R. Saxena Cardiovascular effects of centrally administered endothelin-1 in rats J. Cardiovasc. Pharmacol. 26 1995 S244 S246
16. A. Gulati, S. Rebello, and A. Kumar Role of sympathetic nervous system in cardiovascular effects of centrally administered endothelin-1 in rats Am. J. Physiol. 273 1997 H1177 H1186
17. T.J. Haley, and W.G. McCormick Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse Br. J. Pharmacol. 12 1957 12 15
18. C. Hansen, I. Gilron, and M. Hong The effects of intrathecal gabapentin on spinal morphine tolerance in the rat tail-flick and paw pressure tests Anesth. Analg. 99 2004 1180 1184
19. L. He, J. Fong, M. von Zastrow, and J.L. Whistler Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization Cell 108 2002 271 282
20. M. Ihara, K. Ishikawa, T. Fukuroda, T. Saeki, K. Funabashi, T. Fukami, H. Suda, and M. Yano In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor J. Cardiovasc. Pharmacol. 20 Suppl. 12 1992 S11 S14
21. M.F. Jarvis, J.L. Wessale, C.Z. Zhu, J.J. Lynch, B.D. Dayton, S.V. Calzadilla, R.J. Padley, T.J. Opgenorth, and E.A. Kowaluk ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain Eur. J. Pharmacol. 388 2000 29 35
22. D.E. Keith, S.R. Murray, P.A. Zaki, P.C. Chu, D.V. Lissin, L. Kang, C.J. Evans, and M. von Zastrow Morphine activates opioid receptors without causing their rapid internalization J. Biol. Chem. 271 1996 19021 19024
23. A. Khodorova, B. Navarro, L.S. Jouaville, J.E. Murphy, F.L. Rice, J.E. Mazurkiewicz, D. Long-Woodward, M. Stoffel, G.R. Strichartz, R. Yukhananov, and G. Davar Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury Nat. Med. 9 2003 1055 1061
24. H. Koyuncuoglu, M. Gungor, H. Sagduyu, and F. Aricioglu Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats Pharmacol. Biochem. Behav. 35 1990 829 832
25. A. Kumar, B.T. Shahani, and A. Gulati Modification of systemic and regional circulatory effects of intracerebroventricular administration of endothelin-1 by propranolol in anesthetized rats Gen. Pharmacol. 27 1996 1025 1033
26. P.Y. Law, and H.H. Loh Regulation of opioid receptor activities J. Pharmacol. Exp. Ther. 289 1999 607 624
27. S. Liu, R.T. Premont, C.D. Kontos, J. Huang, and D.C. Rockey Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein betagamma subunit signaling to protein jinase B/Akt J. Biol. Chem. 278 2003 49929 49935
28. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
29. M.W. MacCumber, C.A. Ross, and S.H. Snyder Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells Proc. Natl. Acad. Sci. U. S. A. 87 1990 2359 2363
30. C.E. Maher, D.E. Selley, and S.R. Childers Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions Biochem. Pharmacol. 59 2000 1395 1401
31. R. Maldonado, L. Stinus, and G.F. Koob Neuropsychopharmacology of opiate dependence R. Maldonado L. Stinus G.F. Koob Neurobiological Mechanisms of Opiate Withdrawal 1996 Springer New York 77 124
32. J. Mao, D.D. Price, and D.J. Mayer Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C J. Neurosci. 14 1994 2301 2312
33. P. Marek, S. Ben-Eliyahu, M. Gold, and J.C. Liebeskind Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat Brain Res. 547 1991 77 81
34. D.J. Mayer, J. Mao, J. Holt, and D.D. Price Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions Proc. Natl. Acad. Sci. U. S. A. 96 1999 7731 7736
35. 35S]-GTPgammaS binding and immunohistochemistry Br. J. Pharmacol. 128 1999 1300 1306
36. M. Narita, H. Mizoguchi, H. Nagase, T. Suzuki, and L.F. Tseng Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment Brain Res. 913 2001 170 173
37. F. Noble, and B.M. Cox Differential desensitization of mu- and delta-opioid receptors in selected neural pathways following chronic morphine treatment Br. J. Pharmacol. 117 1996 161 169
38. A.P. Piovezan, P. D'Orleans-Juste, C.R. Tonussi, and G.A. Rae Effects of endothelin-1 on capsaicin-induced nociception in mice Eur. J. Pharmacol. 351 1998 15 22
39. A.P. Piovezan, P. D'Orleans-Juste, M. Frighetto, G.E. Souza, M.G. Henriques, and G.A. Rae Endothelins contribute towards nociception induced by antigen in ovalbumin-sensitised mice Br. J. Pharmacol. 141 2004 755 763
40. A.P. Piovezan, P. D'Orleans-Juste, G.E. Souza, and G.A. Rae Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ET(B) receptor activation Br. J. Pharmacol. 129 2000 961 968
41. R.B. Raffa, J.J. Schupsky, R.P. Martinez, and H.I. Jacoby Endothelin-1-induced nociception Life Sci. 49 1991 PL61 PL65
42. R.B. Raffa, J.J. Schupsky, D.K. Lee, and H.I. Jacoby Characterization of endothelin-induced nociception in mice: evidence for a mechanistically distinct analgesic model J. Pharmacol. Exp. Ther. 278 1996 1 7
43. K. Rasmussen, R.W. Fuller, M.E. Stockton, K.W. Perry, R.M. Swinford, and P.L. Ornstein NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal Eur. J. Pharmacol. 197 1991 9 16
44. K. Rasmussen, W.T. Kendrick, J.H. Kogan, and G.K. Aghajanian A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal Neuropsychopharmacology 15 1996 497 505
45. S. Rebello, S. Roy, P.R. Saxena, and A. Gulati Systemic hemodynamic and regional circulatory effects of centrally administered endothelin-1 are mediated through ETA receptors Brain Res. 676 1995 141 150
46. T. Sakurai, M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor Nature 348 1990 732 735
47. D.E. Selley, E.J. Nestler, C.S. Breivogel, and S.R. Childers Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment Brain Res. 746 1997 10 18
48. M. Tomic, F. Van Goor, M.L. He, D. Zivadinovic, and S.S. Stojilkovic Ca(2+)-mobilizing endothelin-A receptors inhibit voltage-gated Ca(2+) influx through G(i/o) signaling pathway in pituitary lactotrophs Mol. Pharmacol. 61 2002 1329 1339
49. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells Mol. Pharmacol. 47 1995 848 854
50. J.R. Traynor, M.J. Clark, and A.E. Remmers Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists J. Pharmacol. Exp. Ther. 300 2002 157 161
51. K.A. Trujillo Cellular and molecular mechanisms of opioid tolerance and dependence: progress and pitfalls. Pain Forum 8 1999 29 33
52. K.A. Trujillo, and H. Akil Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801 Science 251 1991 85 87
53. K.A. Trujillo, and H. Akil The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality Pharmacol. Biochem. Behav. 38 1991 673 675
54. A.L. Vaccarino, and A.J. Kastin Endogenous opiates: 1999 Peptides 21 2000 1975 2034
55. A.L. Vaccarino, and A.J. Kastin Endogenous opiates: 2000 Peptides 22 2001 2257 2328
56. J.M. Van Ree, M.A.F.M. Gerritis, and L.J.M.J. Vanderschuren Opioids, reward and addiction: an encounter of biology, psychology, and medicine Pharmacol. Rev. 51 1999 342 396
57. X. Wang, H. Xu, and R.B. Rothman Intracerebroventricular administration of anti-endothelin-1 IgG selectively upregulates endothelin-A and kappa opioid receptors Neuroscience 129 2004 751 756
58. M.L. Webb, J.E. Bird, E.C. Liu, P.M. Rose, R. Serafino, P.D. Stein, and S. Moreland BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist J. Pharmacol. Exp. Ther. 272 1995 1124 1134
59. J.L. Whistler, H.H. Chuang, P. Chu, L.Y. Jan, and M. von Zastrow Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction Neuron 23 1999 737 746
60. J.T. Williams, M.J. Christie, and O. Manzoni Cellular and synaptic adaptations mediating opioid dependence Physiol. Rev. 81 2001 299 343
61. N. Yabaluri, and F. Medzihradsky Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling Mol. Pharmacol. 52 1997 896 902
62. M. Yanagisawa, H. Kurihara, S. Kimura, K. Goto, and T. Masaki A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels J. Hypertens., Suppl. 6 1988 S188 S191
63. B.C. Yoburn, K. Lutfy, S. Azimuddin, and V. Sierra Differentiation of spinal and supraspinal opioid receptors by morphine tolerance Life Sci. 46 1990 343 350
64. Z. Zhou, G. Davar, and G. Strichartz Endothelin-1 (ET-1) selectively enhances the activation gating of slowly inactivating tetrodotoxin-resistant sodium currents in rat sensory neurons: a mechanism for the pain-inducing actions of ET-1 J. Neurosci. 22 2002 6325 6330